QuantifEye, A new instrument to assess risk factors for age related macular degeneration (AMD) at an early age.

AMD is reaching epidemic proportions and risk assessment for AMD has always been a challenge...
Until Now!

ZeaVision’s new program, QuantifEYE, now gives us the means to determine potential risk for AMD. This program is affordable, results are measurable, and testing is convenient. Baby Boomers are a generation now facing the challenges of AMD. Early risk assessment and prevention needs to start with patients in their 20’s. Our goal is to do everything possible to keep your vision healthy for years to come, and QuantifEYE is another way we can assist you in that goal.

QuantifEye is a comprehensive risk assessment that includes an evaluation of potential health/history factors, measurement of your macular pigment levels, and your retinal exam. This approach ensures everything possible is being done to aid in the prevention of this devastating disease.

---

We have the latest in computerized technology, an OCT scanning device (bottom right). Below is an automated visual field testing instrument. Both instruments help in diagnosing and managing glaucoma and other eye diseases.

---